glycyl-l-phenylalanine has been researched along with glycylproline in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akamatsu, M; Asao, M; Fujita, T; Iwamura, H | 1 |
Collantes, ER; Dunn, WJ | 1 |
Marshall, GR; Waller, CL | 1 |
Fei, YJ; Ganapathy, V; Leibach, FH; Wang, H | 1 |
Faria, TN; Quan, Y; Smith, RL; Stouch, TR; Timoszyk, JK; Vig, BS; Wall, DA | 1 |
Bonini, BM; Thevelein, JM; Van Zeebroeck, G; Versele, M | 1 |
He, Z; Li, T; Lu, D; Qi, W; Su, R; Wu, S | 1 |
Backwell, FR; Schweizer, A; Wilson, D | 1 |
Frølund, S; Holm, R; Kall, MA; Langthaler, L; Nielsen, CU | 1 |
9 other study(ies) available for glycyl-l-phenylalanine and glycylproline
Article | Year |
---|---|
Quantitative structure-activity relationships of the bitter thresholds of amino acids, peptides, and their derivatives.
Topics: Amino Acids; Humans; Mathematics; Peptides; Structure-Activity Relationship; Taste | 1987 |
Amino acid side chain descriptors for quantitative structure-activity relationship studies of peptide analogues.
Topics: Amino Acid Sequence; Amino Acids; Bradykinin; Electrochemistry; Molecular Sequence Data; Peptides; Structure-Activity Relationship; Taste | 1995 |
Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog and com
Topics: Angiotensin-Converting Enzyme Inhibitors; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Thermolysin | 1993 |
Electrophysiological characteristics of the proton-coupled peptide transporter PEPT2 cloned from rat brain.
Topics: Amino Acids; Animals; Biological Transport; Brain; Carrier Proteins; Cell Line; Cloning, Molecular; Dipeptides; HeLa Cells; Humans; Hydrogen-Ion Concentration; Kidney; Kinetics; Neuroprotective Agents; Protons; Rats; Recombinant Proteins; Symporters; Transfection | 1998 |
Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding.
Topics: Animals; Binding Sites; Biological Transport; Cell Line; Dipeptides; Dogs; Electricity; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Peptide Transporter 1; Proline; Protein Binding; Protein Conformation; Structure-Activity Relationship; Symporters | 2006 |
Transport and signaling via the amino acid binding site of the yeast Gap1 amino acid transceptor.
Topics: Amino Acid Transport Systems; Amino Acids; Biological Transport; Catalytic Domain; Dipeptides; Gene Expression Regulation, Fungal; Mutagenesis; Protein Conformation; Protein Structure, Tertiary; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Signal Transduction | 2009 |
CoMFA and CoMSIA analysis of ACE-inhibitory, antimicrobial and bitter-tasting peptides.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Anti-Infective Agents; Models, Molecular; Peptides; Quantitative Structure-Activity Relationship; Regression Analysis; Taste | 2014 |
Evidence for a glycyl-proline transport system in ovine enterocyte brush-border membrane vesicles.
Topics: Animals; Biological Transport; Cell Fractionation; Dipeptides; Duodenum; Hydrogen-Ion Concentration; Intestinal Mucosa; Kinetics; Microvilli; Sheep | 1995 |
Intestinal drug transport via the proton-coupled amino acid transporter PAT1 (SLC36A1) is inhibited by Gly-X(aa) dipeptides.
Topics: Administration, Oral; Amino Acid Transport Systems; Animals; Biological Transport; Caco-2 Cells; Cell Membrane Permeability; Dipeptides; Glycine; Humans; Intestinal Absorption; Intestinal Mucosa; Intestines; Isoxazoles; Male; Oocytes; Protons; Rats; Rats, Sprague-Dawley; Symporters; Xenopus laevis | 2012 |